• 21ST MARCH 2023

    PQS: NHSE publishes 2019/20 high risk audit report

    NHS England (NHSE) has published a report on the high risk medicines audit* from the 2019/20 Pharmacy Quality Scheme (PQS). 10,673 (90%) community pharmacy contractors participated in the audit and 40,419 patients were audited. This audit shows that pharmacists and pharmacy teams have a very important role in ensuring that high risk medicines are understood

    Read more
    • 21ST MARCH 2023

    MHRA Class 3 Medicines Recall: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd)

    Drug alert number: EL(23)A/11 Date issued: 21 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) – PL 00427/0258 Batch Number Expiry Date Pack Size First Distributed SLD22002 April 2025 122ml June 2022 Active Pharmaceutical Ingredients: Sildenafil (as Citrate)

    Read more
    • 20TH MARCH 2023

    Peers hold parliamentary debate on community pharmacy

    Community pharmacies received strong backing today in the House of Lords, with a number of Peers speaking out in support of pharmacies and others asking when Government would address the current crisis in the sector. The House of Lords oral questions session was opened by Baroness Hodgson on behalf of Baroness Cumberlege as follows: “To

    Read more
    • 20TH MARCH 2023

    PSNC Elections – final stage of voting

    Contractors are currently voting in four PSNC regional representative ballots and PSNC’s (national) non-CCA Multiple representatives ballot. We have been requesting for contractors to make their vote as soon as possible before the voting deadlines. The voting allocations for the ballots are based on records of contractors’ NHS pharmacy premises and earlier this year contractors

    Read more
    • 20TH MARCH 2023

    Save our Pharmacies campaign gains momentum

    Pharmacy leaders are set to brief MPs on the severe challenges facing community pharmacies this week as part of a wave of #SaveOurPharmacies campaign activities. Tomorrow’s (Tuesday 21st March) roundtable summit will include discussions on the urgent action needed to address the current severe challenges being faced by community pharmacy, as well as the sector’s

    Read more
    • 17TH MARCH 2023

    SSP issued for Paracetamol 240mg suppositories

    In response to a significant ongoing disruption to the supply of Paracetamol 240mg suppositories , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 17 March 2023, SSP051 provides that for every Paracetamol 240mg suppository originally prescribed, one Paracetamol 250mg suppository must be supplied. SSP051, authorised by the

    Read more
    • 17TH MARCH 2023

    Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

    The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 100mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP049 Estradot® 100mcg patches expires at 23.59pm on Friday 17 March 2023. After this date, any prescriptions for Estradot® 100mcg patches must be

    Read more
    • 17TH MARCH 2023

    MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

    Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (23)A/10 Date issued: 16 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 150mg prolonged-release tablets, PL01883/0340 SNOMED Code: 41468211000001100 Batch

    Read more
    • 16TH MARCH 2023

    Free clinical examination skills training for community pharmacists

    Health Education England (HEE) has announced a new NHS-funded training course for 10,000 community pharmacists on clinical examination skills. The training, which will be coordinated by HEE with the Pharmacy Integration Programme at NHS England, will be provided by CliniSkills. The training will be delivered online, with optional face-to-face attendance for pharmacists who would find

    Read more
    • 16TH MARCH 2023

    Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream. MSN/2023/028 Tier 2 – medium impact Date of issue 16th March 2023 Following intermittent supplies of capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream, these are now out of stock until end of June 2023.

    Read more